PRESS RELEASE published on 05/28/2026 at 16:00, 5 months 13 days ago Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders Jaguar Health's crofelemer, an FDA-approved botanical drug derived from Croton lechleri tree, developed as first oral adjunctive therapy for Intestinal Failure (IF) from MVID and SBS, highlighting unique botanical drug platform and indigenous collaboration Crofelemer Jaguar Health FDA-approved Botanical Drug Intestinal Failure
PRESS RELEASE published on 05/28/2026 at 15:53, 5 months 13 days ago Result of AGM Irish Residential Properties REIT plc announces successful passing of all resolutions at the AGM held on 28 May 2026 Shareholders AGM Resolutions Irish Residential Properties REIT Voting
PRESS RELEASE published on 05/28/2026 at 15:40, 5 months 13 days ago Galantas Gold Completes $100 Million Private Placement Galantas Gold completes $100 million private placement of 181,819,000 units at $0.55, led by Canaccord Genuity Corp. Funding projects in Chile with Eric Sprott and Ocean Partners' support Private Placement Eric Sprott Galantas Gold Chile Projects Canaccord Genuity Corp
PRESS RELEASE published on 05/28/2026 at 15:35, 5 months 13 days ago Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion Haier Biomedical named No. 1 in global life science lab equipment sales by Euromonitor, achieving top rankings in total and overseas sales among Chinese-owned brands International Expansion Global Ranking Haier Biomedical Life Science Equipment Euromonitor
PRESS RELEASE published on 05/28/2026 at 15:23, 5 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses owning 4.74% of Tate & Lyle plc's relevant securities as of 27 May 2026, with recent trading activity Trading The Vanguard Group, Inc. Relevant Securities Disclosure Tate & Lyle Plc
PRESS RELEASE published on 05/28/2026 at 15:22, 5 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.59% stake in Spire Healthcare Group plc as of 27 May 2026. Details of open positions revealed through Form 8.3 Form 8.3 Financial Dealings Vanguard Group Stake Disclosure Spire Healthcare Group
PRESS RELEASE published on 05/28/2026 at 15:21, 5 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Senior plc The Vanguard Group, Inc. discloses 5.12% stake in Senior plc as of 27 May 2026. Full details in the Form 8.3 filing Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure Senior Plc
PRESS RELEASE published on 05/28/2026 at 15:20, 5 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.56% ownership in Schroders plc. Form 8.3 submitted in compliance with Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Schroders Plc Vanguard Group Ownership Disclosure
PRESS RELEASE published on 05/28/2026 at 15:20, 5 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group discloses a 5.14% stake in NCC Group plc through Form 8.3. Details of ownership and recent dealings included Form 8.3 Securities Dealings Vanguard Group Ownership Disclosure NCC Group Plc
PRESS RELEASE published on 05/28/2026 at 15:20, 5 months 13 days ago Formation Metals Inc. Provides Corporate Update Following C$22.4 Million Financing, Announces Participation in The Mining Investment Event, and Hosts Live CEO Investor Webinar Formation Metals Inc. provides corporate update on N2 Gold Project drill program, financing, and upcoming events. CEO Varshney to host live webinar and present at The Mining Investment Event in Quebec City Drill Program Mining Investment Event N2 Gold Project CEO Deepak Varshney Formation Metals Inc.
Published on 11/10/2026 at 21:00, 38 minutes ago Golden Minerals Announces Completion of Offering for C$5,000,000
Published on 11/10/2026 at 14:45, 6 hours 53 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 7 hours 7 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 7 hours 8 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 7 hours 8 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 18:54, 2 hours 44 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 2 hours 53 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 3 hours 8 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 17:31, 4 hours 7 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 7 hours 38 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 10 hours 36 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 14 hours 38 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 3 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond